Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
Stock
ALNY
ALNY News & Events
-
Add to Watchlist
Trade ALNY
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Forecast
Technical
Valuation
Financials
Earnings
Should I Buy
News
ALNY News
Alnylam Pharmaceuticals Q4 2025 Earnings Outlook
Jan 28 2026
Fool
Marvell Technology and Others May Join S&P 500
Jan 16 2026
CNBC
Rare Disease Biotechs Show Strong 2025 Performance with Cashflow and R&D Expansion
Jan 14 2026
Yahoo Finance
S&P 500 Hits Record High as Data Storage Stocks Lead Gains
Jan 13 2026
NASDAQ.COM
Trump Pressures Fed, Credit Card Stocks Slide Amid Legal Threats
Jan 12 2026
NASDAQ.COM
Trump Pressures Fed, Stock Markets Dip Slightly Amid Concerns
Jan 12 2026
NASDAQ.COM
Alnylam Pharmaceuticals Unveils 'Alnylam 2030' Strategy Targeting 25% Annual Revenue Growth
Jan 12 2026
Benzinga
Gold and Silver Hit Record Highs as Investors Reassess Fed Independence Amid Political Tensions
Jan 12 2026
Benzinga
Show More News
ALNY Events
No data
ALNY Monitor News
Alnylam Pharmaceuticals shows strong sales growth potential for 2026
Jan 20 2026
Alnylam Pharmaceuticals Projects Significant Revenue Growth by 2026
Jan 12 2026
Alnylam Pharmaceuticals falls amid broader market weakness
Jan 08 2026
Alnylam Pharmaceuticals rises on market strength
Jan 07 2026
Alnylam Pharmaceuticals hits a 20-day low amid market strength
Jan 05 2026
Alnylam Pharmaceuticals hits a 20-day low amid market decline
Dec 12 2025
Alnylam Pharmaceuticals Inc Hits 20-Day Low Amid Market Weakness
Dec 09 2025
Alnylam Pharmaceuticals Faces Decline Amid Board Changes
Dec 08 2025
Show More Monitor News
ALNY Earnings Analysis
Resilient Growth and Strategic Advances over Year - Intellectia AI™
11 months ago
Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results
1 years ago
People Also Watch
